Top Markets
#1 MowCat MowCat +48.96%
#2 Velvet Velvet +32.75%
#3 Audiera Audiera +25.14%
#4 Derive Derive +19.55%
#5 Quack AI Quack AI +17.50%
#6 Biconomy Biconomy +15.21%
#7 aPriori aPriori +14.35%
#8 Cross Cross +12.67%
#9 Humanity Humanity +11.35%
#10 Geodnet Geodnet +10.81%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
InhaleRx Limited InhaleRx Limited

InhaleRx Limited

IRX
Clasificación en acciones #35421
Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is... Established in 2016 and headquartered in Sydney, Australia, InhaleRx Limited is an Australian company primarily engaged in advancing and bringing to market medical drug delivery systems. The firm also dedicates efforts to developing specialized inhaled drug formulations. A notable product within its portfolio is the Medihale inhaler, a distinctive sealed-pod device engineered for compatibility with its inhaled medications. This entity formerly traded as Lifespot Health Ltd, officially adopting the name InhaleRx Limited in October 2021.
Precio por acción
$0.01657419
Última sincronización: 2026-03-13
Capitalización bursátil
$3.93M
Cambio (1 día)
0.00%
Cambio (1 año)
-31.14%
País
AU
Comercio InhaleRx Limited (IRX)

Categoría

Healthcare
Ratio P/S de InhaleRx Limited (IRX)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de InhaleRx Limited, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de InhaleRx Limited desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 -
US